Literature DB >> 18329700

The effects of two highly selective dopamine D3 receptor antagonists (SB-277011A and NGB-2904) on food self-administration in a rodent model of obesity.

Panayotis K Thanos1, Michael Michaelides, Christopher W Ho, Gene-Jack Wang, Amy H Newman, Christian A Heidbreder, Charles R Ashby, Eliot L Gardner, Nora D Volkow.   

Abstract

In the current study, we examined the effect of the selective D(3) receptor antagonists SB-277011A and NGB 2904 on operant food self-administration (FSA) in Zucker obese and lean rats. Obese (Ob) and lean (Le) Zucker rats were maintained under a restricted feeding regimen (70% of ad-libitum rat chow) and were trained to lever press for food during daily, 2 hour fixed-ratio 4 (FR4) schedules. Once rats reached a stable baseline for FSA, they were injected with vehicle until a stable FSA criterion was achieved. Animals then received daily injections of different random doses of SB-277011A (3, 10, and 30 mg/kg i.p.), and NGB-2904 (0.3, 1 and 3 mg/kg i.p.). SB-277011A produced a significant decrease in both food intake and active lever responses in both Ob and Le rats. In contrast, NGB-2904 did not decrease food intake levels or lever presses for food in Ob and Le rats. These results suggest that along with its involvement in seeking behavior for drugs of abuse, the D(3) dopamine receptor may also be involved in seeking behavior for natural reinforcers such as food.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329700      PMCID: PMC2681081          DOI: 10.1016/j.pbb.2008.02.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  75 in total

Review 1.  How can drug addiction help us understand obesity?

Authors:  Nora D Volkow; Roy A Wise
Journal:  Nat Neurosci       Date:  2005-05       Impact factor: 24.884

2.  Youth WAVE Screener: addressing weight-related behaviors with school-age children.

Authors:  Carmen R Isasi; Nafisseh Soroudi; Judith Wylie-Rosett
Journal:  Diabetes Educ       Date:  2006 May-Jun       Impact factor: 2.140

Review 3.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

Authors:  Christian A Heidbreder; Eliot L Gardner; Zheng-Xiong Xi; Panayotis K Thanos; Manolo Mugnaini; Jim J Hagan; Charles R Ashby
Journal:  Brain Res Brain Res Rev       Date:  2005-07

Review 4.  Role of brain dopamine in food reward and reinforcement.

Authors:  Roy A Wise
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

5.  The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.

Authors:  Zheng-Xiong Xi; Amy Hauck Newman; Jeremy G Gilbert; Arlene C Pak; Xiao-Qing Peng; Charles R Ashby; Leah Gitajn; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2005-10-05       Impact factor: 7.853

Review 6.  The global obesity epidemic: snacking and obesity may start with free meals during infant feeding.

Authors:  Charlotte Erlanson-Albertsson; Rolf Zetterström
Journal:  Acta Paediatr       Date:  2005-11       Impact factor: 2.299

7.  Opposing crosstalk between leptin and glucocorticoids rapidly modulates synaptic excitation via endocannabinoid release.

Authors:  Renato Malcher-Lopes; Shi Di; Victor S Marcheselli; Feng-Ju Weng; Christopher T Stuart; Nicolas G Bazan; Jeffrey G Tasker
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

Review 8.  Energy balance and food intake: the role of PPARgamma gene polymorphisms.

Authors:  Joanne E Cecil; Peter Watt; Colin N Palmer; Marion Hetherington
Journal:  Physiol Behav       Date:  2006-06-13

9.  Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.

Authors:  Jeremy G Gilbert; Amy Hauck Newman; Eliot L Gardner; Charles R Ashby; Christian A Heidbreder; Arlene C Pak; Xiao-Qing Peng; Zheng-Xiong Xi
Journal:  Synapse       Date:  2005-07       Impact factor: 2.562

10.  The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats.

Authors:  Panayotis K Thanos; John M Katana; Charles R Ashby; Michael Michaelides; Eliot L Gardner; Christian A Heidbreder; Nora D Volkow
Journal:  Pharmacol Biochem Behav       Date:  2005-05       Impact factor: 3.533

View more
  24 in total

1.  Selectivity and activation of dopamine D3R from molecular dynamics.

Authors:  Zhiwei Feng; Tingjun Hou; Youyong Li
Journal:  J Mol Model       Date:  2012-07-03       Impact factor: 1.810

Review 2.  Dopaminergic mechanism of reward-related incentive learning: focus on the dopamine D(3) receptor.

Authors:  R J Beninger; T J Banasikowski
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

3.  Imaging of brain dopamine pathways: implications for understanding obesity.

Authors:  Gene-Jack Wang; Nora D Volkow; Panayotis K Thanos; Joanna S Fowler
Journal:  J Addict Med       Date:  2009-03       Impact factor: 3.702

4.  Development of molecular tools based on the dopamine D3 receptor ligand FAUC 329 showing inhibiting effects on drug and food maintained behavior.

Authors:  Anne Stößel; Regine Brox; Nirupam Purkayastha; Harald Hübner; Carsten Hocke; Olaf Prante; Peter Gmeiner
Journal:  Bioorg Med Chem       Date:  2017-04-29       Impact factor: 3.641

5.  Cocaine self-administration disrupts mesolimbic dopamine circuit function and attenuates dopaminergic responsiveness to cocaine.

Authors:  Cody A Siciliano; Mark J Ferris; Sara R Jones
Journal:  Eur J Neurosci       Date:  2015-06-28       Impact factor: 3.386

Review 6.  Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders.

Authors:  Christian Heidbreder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-28       Impact factor: 3.000

7.  A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[(11)C]methyl)benperidol.

Authors:  Sarah A Eisenstein; Jo Ann V Antenor-Dorsey; Danuta M Gredysa; Jonathan M Koller; Emily C Bihun; Samantha A Ranck; Ana Maria Arbeláez; Samuel Klein; Joel S Perlmutter; Stephen M Moerlein; Kevin J Black; Tamara Hershey
Journal:  Synapse       Date:  2013-05-30       Impact factor: 2.562

Review 8.  Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction.

Authors:  Bernard Le Foll; Patricia Di Ciano
Journal:  Eur Neuropsychopharmacol       Date:  2014-09-16       Impact factor: 4.600

9.  The highly selective dopamine D3R antagonist, R-VK4-40 attenuates oxycodone reward and augments analgesia in rodents.

Authors:  Chloe J Jordan; Bree Humburg; Myra Rice; Guo-Hua Bi; Zhi-Bing You; Anver Basha Shaik; Jianjing Cao; Alessandro Bonifazi; Alexandra Gadiano; Rana Rais; Barbara Slusher; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropharmacology       Date:  2019-04-08       Impact factor: 5.250

10.  The dopamine D3 receptor partial agonist CJB 090 inhibits the discriminative stimulus but not the reinforcing or priming effects of cocaine in squirrel monkeys.

Authors:  Cindy Achat-Mendes; Donna M Platt; Amy H Newman; Roger D Spealman
Journal:  Psychopharmacology (Berl)       Date:  2009-06-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.